This protocol covers portal hypertension presenting alongside hyponatremia in a patient with cirrhosis — a common and clinically significant complication in which hypervolemia is the predominant mechanism driving the sodium deficit.
Hypervolemia is the most common cause of hyponatremia in patients with cirrhosis. Addressing the sodium imbalance is a central priority in management alongside the underlying portal hypertension.
Structured management includes specific adjustments to ongoing medications and targeted strategies to support sodium correction. The complete regimen — including sequencing and the full set of interventions — is available via the link below.
Goal: Correction of hyponatremia — increase in serum sodiumHypervolemia is the most common cause of hyponatremia in patients with cirrhosis.
The first step in the management of hyponatremia is to stop diuretics after a thorough clinical examination for features of hypervolemia.
Free water restriction (<1000 ml/day) is recommended only for patients with serum sodium <125 meq/dl.
Human albumin solution can increase serum sodium levels in patients with cirrhosis.
Therefore, hypokalemia correction may improve hyponatremia.
View source ↗